Figure 1 provides an overview of the AML-mutation-specific TF network pipeline used by Assi et al. In step A of Figure 1, high-depth DNaseI-Seq data (an average of more than 200 million sequence reads) were generated from all 32 AML samples, with several samples for each mutation-specific subset. This evidence concerns the gene TF and acute myeloid leukemia.